Therefore, sensitivity analyses were performed for additional pathologies that might contribute to cortical thinning and neuronal loss, including neuritic beta-amyloid plaques, AD-type tau pathology, and TDP-43 inclusions. Here, MAPT is linked to Alzheimer disease.